H. P. T. Ammon

Dr. H. P. T. Ammon

Department of Pharmacology, Toxicology, and Clinical Pharmacy, Institute of Pharmaceutical Sciences, University of Tuebingen, Tuebingen, Germany

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2006 in Planta Medica
Verified
Journal Article
Closed access
PDF file
HAH. P. T. Ammon
H. P. T. Ammon
Oleogum resins from Boswellia species are used in traditional medicine in India and African countries for the treatment of a variety of diseases. Animal experiments showed anti-inflammatory activity of the extract. The mechanism of this action is due to some boswellic acids. It is different from that of NSAID and is related to components of the immune system. The most evident action is the inhibition of 5-lipoxygenase. However, other factors such as cytokines (interleukins and TNF-α) and the complement system are also candidates. Moreover, leukocyte elastase and oxygen radicals are targets. Clinical studies, so far with pilot character, suggest efficacy in some autoimmune diseases including rheumatoid arthritis, Crohn’s disease, ulcerative colitis and bronchial asthma. Side effects are not severe when compared to modern drugs used for the treatment of these diseases. AKBA:Acetyl-11-keto-β-boswellic acid BA:Boswellic acid BE:Extract from oleogum resin of Boswellia serrata BS:Boswellia serrata BSA:Bovine serum albumin [Ca2+]:Cytosolic calcium concentration CHE:Cholinesterase Con A:Concanavalin A COX1:Cyclooxygenase 1 COX2:Cyclooxygenase 2 cPLA:Phospholipase A CRP:C-reactive protein EC50:Effective concentration 50 ESR:Erythrocyte sedimentation rate FEV1:Forced expiratory volume in 1 sec (liters) FLAP:5-Lipoxygenase activating protein fMLP:n-Formyl-methionyl-leucyl-phenylalanin FVC:Forced vital capacity (liters) HAB:Homöopathisches Arzneibuch (German homeopathic pharmacopoeia) 5-HETE:5-Hydroxyeicosatetraenoic acid 12-HETE:12-Hydroxyeicosatetraenoic acid 12-HHT:12-Hydroxyheptadecatrienoic acid HLE:Human leucocyte elastase IC50:Inhibitory concentration 50 5-LO:5-Lipoxygenase IKK:IκBα kinase IL-1:Interleukin-1 IL-2:Interleukin-2 KBA:11-Keto-β-boswellic acid LPS:Lipopolysaccharide LTB4:Leukotriene B4 LTC4:Leukotriene C4 LTD4:Leukotriene D4 LTE4:Leukotriene E4 MAPK:Mitogen activated protein kinase MCH:Mean corpuscular haemoglobin MCHC:Mean corpuscular haemoglobin concentration MCV:Mean corpuscular volume MEK:Mitogen activated protein kinase kinase NSAID:Non-steroidal anti-inflammatory drug P38:p38 kinase P42:p42 kinase PEFR:Peak expiratory flowrate PGF 1α:Prostaglandin F 1α PHA:Phytohaemagglutinin PI3-K:Phosphatidylinositol 3-kinase PMNs:Polymorphonuclear neutrophils RAS:21 kDA-GTP-binding protein TA:Tirucallic acid TH1:T-Helper cells 1 TH2:T-Helper cells 2 TNFα:Tumor necrosis factor α

1 September 2010 in Phytomedicine
Verified
Journal Article
Closed access
HAH. P. T. Ammon
H. P. T. Ammon



1 October 2019 in Phytomedicine
Verified
Journal Article
Open access
HAH. P. T. Ammon
H. P. T. Ammon
Type 1 diabetes is an autoimmune disease directed to the pancreatic islets where inflammation leads to the death of insulin-producing ß cells and insulin deficiency. Type 2 diabetes, which is closely related to overweight, is characterized by insulin resistance. In both cases, proinflammatory cytokines play an important role by causing insulitis and insulin resistance. The gum resin of Boswellia species and its pharmacologically active compounds, including 11-keto-ß-boswellic acids have been shown to suppress the expression of proinflammatory cytokines in various immune-competent cells. To review the present evidence of the therapeutic effects of boswellic extracts (BE) and/or 11-keto-ß-boswellic acids in the prevention/treatment of diabetes mellitus and to provide comprehensive insights into the underlying molecular mechanisms. This review considers all available informations from preclinical and clinical studies concerning BEs, 11-keto-ß-boswellic acids, proinflammatory cytokines and diabetes mellitus collected via electronic search (PubMed) and related publications of the author. Type 1 diabetes: Studies in mice with autoimmune diabetes revealed that in the model of multiple injections of low doses of streptozotocin (MLD-STZ), an extract of the gum resin of Boswellia serrata and 11-keto-ß-boswellic acid (KBA) suppressed the increase in proinflammatory cytokines in the blood, infiltration of lymphocytes into pancreatic islets and increase in blood glucose. In a second model, i.e. the nonobese diabetic (NOD) mouse, KBA prevented the infiltration of lymphocytes into pancreatic islets. Regarding the clinical effects, a case report provided evidence that BE suppressed the blood levels of tyrosine phosphatase antibody (IA2-A), a marker for insulitis, in a patient with late-onset autoimmune diabetes of the adult (LADA). Type 2 diabetes: In a preclinical study in rats where obesity was alimentary induced, the administration of BE significantly reduced food intake, overweight, proinflammatory cytokines such as interleukin-1ß (IL-1ß), and tumor necrosis factor-α (TNF-α) and ameliorated the parameters of glucose and lipid metabolism. Similar results were obtained in a second animal study, where type 2 diabetes was induced by a combination of a high-fat/high-fructose diet and a single dose of streptozotocin. Two clinical trials with patients with type 2 diabetes receiving the resin of Boswellia serrata demonstrated improvement in the blood glucose, HbA1c and lipid parameters. Preclinical and clinical data suggest that BE and/or 11-keto-ß-boswellic acids by inhibiting the expression of proinflammatory cytokines from immune-competent cells, may prevent insulitis and insulin resistance in type 1 and type 2 diabetes, respectively, and therefore may be an option in the treatment/prevention of type 1 and type 2 diabetes. It is hypothesized that molecularly, BE and 11-keto-ß-boswellic acids act via interference with the IκB kinase/Nuclear Transcription Factor-κB (IKK/NF-κB) signaling pathway through inhibition of the phosphorylation activity of IKK. However, further investigations and well-designed clinical studies are required.

7 May 2015 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
ASA. M. Shehata
A. M. Shehata
LQL. Quintanilla-Fend
L. Quintanilla-Fend
SBS. Bettio
S. Bettio
JJJ. Jauch
J. Jauch
TSThomas Scior
Thomas Scior
HAH. P. T. Ammon
H. P. T. Ammon
The aim of the work was to study whether or not 11-keto-β-boswellic acids prevent induction of autoimmune reactions, insulitis, and hyperglycemia in the model of multiple low-dose streptozotocin (MLD-STZ) diabetes. Using male mice (n=6) diabetes was induced by daily i.p. injections of 40 mg/kg STZ for 5 days. In a second series together with STZ, daily i. p. injections of 11-keto-β-boswellic acid (KBA) and O-acetyl-11-keto-β-boswellic acid (AKBA) (7.5 and 15.0 mg/kg) were applied for 10 days. Thereafter, pro-and anti-inflammatory cytokines in the blood, histochemistry of pancreatic islets, and blood glucose levels were assayed. Five days after the last injection of STZ, a significant burst of pro-and anti-inflammatory cytokines in the blood, infiltration of lymphocytes (CD3) into pancreatic islets, and appearance of peri-insular apoptotic cells were observed. Plasma glucose increased significantly (124.4±6.65 vs. 240.2±27.36 mg/dl, p<0.05). Simultaneous treatment with KBA and AKBA significantly reduced pro-and anti-inflammatory cytokines (IFN-γ p<0.01, p<0.01; IL-1A p<0.001, p<0.001; IL-1B p<0.001, p<0.001; IL-2 p<0.001, p<0.001; IL-6 p<0.01, p<0.001; TNF-α p<0.05, p<0.001; IL-4 p<0.01, p<0.001; IL-10 p<0.001, p<0.001) in the blood. No infiltration of lymphocytes into pancreatic islets and appearance of peri-insular cells were detected. Moreover, KBA and AKBA reduced STZ-mediated increase of blood glucose on day 10 to 163.25±16.6 (p<0.05) and 187.6±19.5 mg/dl (p<0.05), respectively. In the model of MLD-STZ induced diabetes KBA and AKBA prevent cytokine burst, development of insulitis and reduce increase of blood glucose through “silencing” a forced-up immune reaction.